Related references
Note: Only part of the references are listed.Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease
Kamakoti P. Bhat et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Polycomb Gene Silencing Mechanisms: PRC2 Chromatin Targeting, H3K27me3 'Readout', and Phase Separation-Based Compaction
Yiran Guo et al.
TRENDS IN GENETICS (2021)
A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models
Xufen Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
ZMYND11-MBTD1 induces leukemogenesis through hijacking NuA4/TIP60 acetyltransferase complex and a PWWP-mediated chromatin association mechanism
Jie Li et al.
NATURE COMMUNICATIONS (2021)
Integrated requirement of non-specific and sequence-specific DNA binding in Myc-driven transcription
Paola Pellanda et al.
EMBO JOURNAL (2021)
Phase separation drives aberrant chromatin looping and cancer development
Jeong Hyun Ahn et al.
NATURE (2021)
The 9aaTAD Activation Domains in the Yamanaka Transcription Factors Oct4, Sox2, Myc, and Klf4
Martin Piskacek et al.
STEM CELL REVIEWS AND REPORTS (2021)
MYC protein interactors in gene transcription and cancer
Corey Lourenco et al.
NATURE REVIEWS CANCER (2021)
Advancing targeted protein degradation for cancer therapy
Brandon Dale et al.
NATURE REVIEWS CANCER (2021)
Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis
Jue Jiang et al.
CANCER CELL (2020)
UBR5 Is Coamplified with MYC in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
Xi Qiao et al.
CANCER RESEARCH (2020)
Discovery of a first-in-class EZH2 selective degrader
Anqi Ma et al.
NATURE CHEMICAL BIOLOGY (2020)
Target gene-independent functions of MYC oncoproteins
Apoorva Baluapuri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss
Xijuan Liu et al.
MOLECULAR CELL (2020)
A partially disordered region connects gene repression and activation functions of EZH2
Lianying Jiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
No Easy Way Out for EZH2: Its Pleiotropic, Noncanonical Effects on Gene Regulation and Cellular Function
Jun Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader
Frances Potjewyd et al.
CELL CHEMICAL BIOLOGY (2020)
EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasis
Yu Zhao et al.
EMBO JOURNAL (2019)
Gene-Specific H1 Eviction through a Transcriptional Activator → p300 → NAP1 → H1 Pathway
Miho Shimada et al.
MOLECULAR CELL (2019)
MYC Recruits SPT5 to RNA Polymerase II to Promote Processive Transcription Elongation
Apoorva Baluapuri et al.
MOLECULAR CELL (2019)
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
Daisuke Ennishi et al.
CANCER DISCOVERY (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
Marian L. Burr et al.
CANCER CELL (2019)
Development of targeted protein degradation therapeutics
Philip P. Chamberlain et al.
NATURE CHEMICAL BIOLOGY (2019)
Targeted protein degradation: expanding the toolbox
Matthieu Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Targeted in situ genome-wide profiling with high efficiency for low cell numbers
Peter J. Skene et al.
NATURE PROTOCOLS (2018)
ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer
Ling Cai et al.
MOLECULAR CELL (2018)
MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis
Manpreet Kalkat et al.
MOLECULAR CELL (2018)
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator
Jung Kim et al.
CELL REPORTS (2018)
HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation
Kevin B. Myant et al.
EMBO MOLECULAR MEDICINE (2017)
Induced protein degradation: an emerging drug discovery paradigm
Ashton C. Lai et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants
Janet Pinero et al.
NUCLEIC ACIDS RESEARCH (2017)
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Loren M. Lasko et al.
NATURE (2017)
ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia
Liling Wan et al.
NATURE (2017)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs
Michael Allevato et al.
PLOS ONE (2017)
Human cytomegalovirus IE1 downregulates Hes1 in neural progenitor cells as a potential E3 ubiquitin ligase
Xi-Juan Liu et al.
PLOS PATHOGENS (2017)
Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma
Ying Gu et al.
CANCER CELL (2017)
Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis
Tao Jiang et al.
ONCOTARGET (2016)
Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas
Rishi G. Vaswani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structure-Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors
Xiaobao Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
deepTools2: a next generation web server for deep-sequencing data analysis
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2016)
Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer
Cortney L. Lawrence et al.
PLOS ONE (2016)
RECQL4 Promotes DNA End Resection in Repair of DNA Double-Strand Breaks
Huiming Lu et al.
CELL REPORTS (2016)
Clinical and prognostic relevance of EZH2 in breast cancer: A meta-analysis
Xu Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Targeting EZH2 and PRC2 dependence as novel anticancer therapy
Bowen Xu et al.
EXPERIMENTAL HEMATOLOGY (2015)
SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2
Kimberly H. Kim et al.
NATURE MEDICINE (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia
Bowen Xu et al.
BLOOD (2015)
Hijacked in cancer: the KMT2 (MLL) family of methyltransferases
Rajesh C. Rao et al.
NATURE REVIEWS CANCER (2015)
Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide
Eric S. Fischer et al.
NATURE (2014)
EZH2 expands breast stem cells through activation of NOTCH1 signaling
Maria E. Gonzalez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
MYC and Transcription Elongation
Peter B. Rahl et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Genome Recognition by MYC
Arianna Sabo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Single-molecule tracking in live cells reveals distinct target-search strategies of transcription factors in the nucleus
Ignacio Izeddin et al.
ELIFE (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Sequence specificity incompletely defines the genome-wide occupancy of Myc
Jiannan Guo et al.
GENOME BIOLOGY (2014)
An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
Kyle D. Konze et al.
ACS CHEMICAL BIOLOGY (2013)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity
Junli Yan et al.
BLOOD (2013)
EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
Wendy Beguelin et al.
CANCER CELL (2013)
The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
Bryan King et al.
CELL (2013)
Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth
Shivani Garapaty-Rao et al.
CHEMISTRY & BIOLOGY (2013)
An H3K36 Methylation-Engaging Tudor Motif of Polycomb-like Proteins Mediates PRC2 Complex Targeting
Ling Cai et al.
MOLECULAR CELL (2013)
Target analysis by integration of transcriptome and ChIP-seq data with BETA
Su Wang et al.
NATURE PROTOCOLS (2013)
The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;NrasG12D acute myeloid leukemia
J. Shi et al.
ONCOGENE (2013)
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
Sarah K. Knutson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia
Satomi Tanaka et al.
BLOOD (2012)
Acetylation-Dependent Regulation of Skp2 Function
Hiroyuki Inuzuka et al.
CELL (2012)
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Charles Y. Lin et al.
CELL (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
Sarah K. Knutson et al.
NATURE CHEMICAL BIOLOGY (2012)
Polycomb repressive complex 2 is required for MLL-AF9 leukemia
Tobias Neff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
Shuet Theng Lee et al.
MOLECULAR CELL (2011)
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Hiroyuki Inuzuka et al.
NATURE (2011)
Cistrome: an integrative platform for transcriptional regulation studies
Tao Liu et al.
GENOME BIOLOGY (2011)
Fast and accurate long-read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2010)
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
Sven Heinz et al.
MOLECULAR CELL (2010)
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy et al.
NATURE (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V. Krivtsov et al.
NATURE REVIEWS CANCER (2007)
T lymphocytes redirected against the κ light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells
Juan Vera et al.
BLOOD (2006)
Persistent transactivation by Meis1 replaces Hox function in myeloid leukemogenesis models: Evidence for co-occupancy of Meis1-Pbx and Hox-Pbx complexes on promoters of leukemia-associated genes
GG Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53
W An et al.
CELL (2004)
Skp2 regulates Myc protein stability and activity
SY Kim et al.
MOLECULAR CELL (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Share Paper
